American International Group’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,649
Closed -$289K 1335
2024
Q1
$289K Buy
4,649
+205
+5% +$13.3K ﹤0.01% 1936
2023
Q4
$257K Buy
4,444
+39
+0.9% +$2K ﹤0.01% 2036
2023
Q3
$207K Buy
4,405
+682
+18% +$34.1K ﹤0.01% 2101
2023
Q2
$165K Buy
+3,723
New +$132K ﹤0.01% 2283
2022
Q2
Sell
-363
Closed -$15K 3183
2022
Q1
$15K Sell
363
-25
-6% -$1.31K ﹤0.01% 3056
2021
Q4
$34K Sell
388
-12
-3% -$1.18K ﹤0.01% 3042
2021
Q3
$48K Sell
400
-9
-2% -$1.23K ﹤0.01% 3006
2021
Q2
$79 Buy
+409
New +$134K ﹤0.01% 2931

Other funds holding IRON

American International Group's IRON Position: Q2 2024 in Review

American International Group sold out of Disc Medicine (IRON) in Q2 2024, closing a stake of 4,649 shares — an estimated $289K sold.

American International Group first reported a position in IRON in Q2 2021 and held it in 8 quarters. The position peaked at $289K in Q1 2024. 121 funds tracked by Wall St. Rank hold IRON as of Q2 2024.

  • American International Group reported no remaining Disc Medicine position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 4,649 Disc Medicine shares in Q2 2024, an estimated $289K.
  • American International Group first reported a position in Disc Medicine in Q2 2021 and held it in 8 quarters.
  • American International Group's Disc Medicine position peaked at $289K in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.